Although the aberration of LRP6 is observed in many types of cancers with various gene mutation frequencies in the Wnt/β-catenin pathway, there are no reports showing whether LRP6 could behave differently in cancers based on Wnt/β-catenin pathway genetic abnormalities. This evidence concerns the gene LRP6 and cancer.